Mavyret is an oral medication used for the treatment of chronic hepatitis C virus (HCV) infection [1]. The standard dosage for Mavyret is two tablets taken by mouth once daily, with or without food [1].
How long do I need to take Mavyret?
The duration of Mavyret treatment depends on the specific genotype of hepatitis C and whether a patient has previously received treatment [1]. For patients with genotype 1, 2, 3, 4, 5, or 6 HCV infection who have not received treatment before, the recommended duration is eight weeks [1]. Patients with genotype 1 HCV who have been treated previously with certain drug classes, or those with genotype 1, 2, 3, 4, 5, or 6 HCV who have failed prior treatment, may require a 16-week course of Mavyret [1].
What if I miss a dose of Mavyret?
If a dose of Mavyret is missed, it should be taken as soon as possible. However, if it is already close to the time for the next dose, the missed dose should be skipped, and the regular dosing schedule should be resumed [1]. It is important not to take a double dose to make up for a missed one [1].
Are there alternatives to Mavyret for hepatitis C treatment?
Yes, there are other direct-acting antiviral (DAA) medications available for hepatitis C treatment [2]. These may include combinations of drugs like sofosbuvir/ledipasvir (Harvoni), glecaprevir/pibrentasvir (Mavyret), and sofosbuvir/velpatasvir (Epclusa) [2]. The choice of treatment, including Mavyret or an alternative, depends on factors such as the HCV genotype, viral load, liver health, and previous treatment history [2].
When does the Mavyret patent expire?
The patent protection for Mavyret, like other medications, has specific expiry dates. Information on patent expirations can be tracked through resources like DrugPatentWatch.com [3]. This information is crucial for understanding when generic versions of the drug might become available.